ProCE Banner Activity

Phase IIb Protocol 011: Islatravir Plus Doravirine Following Islatravir, Doravirine, Lamivudine Induction in Treatment-Naive Patients Demonstrates Very Low HIV-1 RNA Levels in Patients With Wk 48 Protocol-Defined Virologic Failure

Slideset Download
Conference Coverage
Among 5 patients with protocol-defined virologic failure at Week 48 in this study, none experienced HIV-1 RNA > 200 copies/mL.

Released: July 05, 2020

Expiration: July 04, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grant provided by:

Gilead

Merck Sharp & Dohme Corp.

ViiV Healthcare

Partners

AIDS 2020

ProCE Banner

IAS 2018

ProCE Banner